Awarded contract

Research services

Details

Topic
Research services
Published
17 May 2016

Tender description

Queens University Belfast has appointed a Clinical Research Organisation (CRO) to provide services in respect of managing a Phase II Clinical Trial sponsored by Novartis Pharma. The CRO is required to facilitate a multinational, Phase IIb study in non-Cystic Fibrosis BE patients across Europe. The trial is operating under the Innovative Medicines Initiative (IMI), which is Europe's largest public-private initiative, aiming to speed up the development of better and safer medicines for patients (http://www.imi.europa.eu/).

Timeline

  1. Completed: Award published17 May 2016
    Current notice

About the buyer

Queen's University Belfast is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 73110000 · Research services
  • 73111000 · Research laboratory services
  • 85121200 · Medical specialist services
  • 85145000 · Services provided by medical laboratories

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

21 similar open tenders

See more open tenders related to Research services.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.